Tocilizumab

From WikiMD.org
Jump to navigation Jump to search
Tocilizumab
TermTocilizumab
Short definitionTocilizumab - (pronounced) (toh-sih-LIH-zoo-mab) drug used to treat adults and children 2 years and older with severe or life-threatening cytokine release syndrome caused by a type of immunotherapy called chimeric antigen receptor (CAR) T-cell therapy. Tocilizumab is also used to treat certain types of arthritis and a disease that causes inflammation of the lining of the arteries. 
TypeCancer terms
SpecialtyOncology
LanguageEnglish
SourceNCI
Comments


Tocilizumab - (pronounced) (toh-sih-LIH-zoo-mab) drug used to treat adults and children 2 years and older with severe or life-threatening cytokine release syndrome caused by a type of immunotherapy called chimeric antigen receptor (CAR) T-cell therapy. Tocilizumab is also used to treat certain types of arthritis and a disease that causes inflammation of the lining of the arteries. It is also being studied in the treatment of other conditions. Tocilizumab attaches to receptors for a protein called interleukin-6 (IL-6), which is made by white blood cells and other cells in the body. This can help lower the body's immune response and reduce inflammation. Tocilizumab is a type of monoclonal antibody. Also called Actemra

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski